|
1
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14(Suppl 5): v1–v49. 2012. View Article : Google Scholar :
|
|
2
|
Kong LY, Wu AS, Doucette T, Wei J, Priebe
W, Fuller GN, Qiao W, Sawaya R, Rao G and Heimberger AB:
Intratumoral mediated immunosuppression is prognostic in
genetically engineered murine models of glioma and correlates to
immunotherapeutic responses. Clin Cancer Res. 16:5722–5733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roberts AB and Wakefield LM: The two faces
of transforming growth factor beta in carcinogenesis. Proc Natl
Acad Sci USA. 100:8621–8623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peñuelas S, Anido J, Prieto-Sánchez RM,
Folch G, Barba I, Cuartas I, García-Dorado D, Poca MA, Sahuquillo
J, Baselga J and Seoane J: TGF-beta increases glioma-initiating
cell self-renewal through the induction of LIF in human
glioblastoma. Cancer Cell. 15:315–327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
ten Dijke P and Hill CS: New insights into
TGF-beta-Smad signalling. Trends Biochem Sci. 29:265–273. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
9
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lawler S and Chiocca EA: Emerging
functions of microRNAs in glioblastoma. J Neurooncol. 92:297–306.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Novakova J, Slaby O, Vyzula R and Michalek
J: MicroRNA involvement in glioblastoma pathogenesis. Biochem
Biophys Res Commun. 386:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Silber J, James CD and Hodgson JG:
microRNAs in gliomas: Small regulators of a big problem.
Neuromolecular Med. 11:208–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoo AS, Sun AX, Li L, Shcheglovitov A,
Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW and Crabtree
GR: MicroRNA-mediated conversion of human fibroblasts to neurons.
Nature. 476:228–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao X, Pfaff SL and Gage FH: A functional
study of miR-124 in the developing neural tube. Genes Dev.
21:531–536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei J, Wang F, Kong LY, Xu S, Doucette T,
Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, et al: miR-124
inhibits STAT3 signaling to enhance T cell-mediated immune
clearance of glioma. Cancer Res. 73:3913–3926. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwartz JP and Wilson DJ: Preparation and
characterization of type 1 astrocytes cultured from adult rat
cortex, cerebellum, and striatum. Glia. 5:75–80. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu X, Ozturk F, Liu C, Oakley GG and
Nawshad A: Transforming growth factor-β activates c-Myc to promote
palatal growth. J Cell Biochem. 113:3069–3085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vehlow A and Cordes N: Invasion as target
for therapy of glioblastoma multiforme. Biochim Biophys Acta.
1836:236–244. 2013.PubMed/NCBI
|
|
23
|
Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T,
Song E and Yu F: miR-124 suppresses multiple steps of breast cancer
metastasis by targeting a cohort of pro-metastatic genes in vitro.
Chin J Cancer. 30:821–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lang Q and Ling C: MiR-124 suppresses cell
proliferation in hepatocellular carcinoma by targeting PIK3CA.
Biochem Biophys Res Commun. 426:247–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y
and Liu R: miR-124 radiosensitizes human glioma cells by targeting
CDK4. J Neurooncol. 114:263–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li KK, Pang JC, Ching AK, Wong CK, Kong X,
Wang Y, Zhou L, Chen Z and Ng HK: miR-124 is frequently
down-regulated in medulloblastoma and is a negative regulator of
SLC16A1. Hum Pathol. 40:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu SH, Jiang XJ, Xiao GL, Liu DY and Yuan
XR: miR-124a restoration inhibits glioma cell proliferation and
invasion by suppressing IQGAP1 and β-catenin. Oncol Rep.
32:2104–2110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lv Z and Yang L: miR-124 inhibits the
growth of glioblastoma through the downregulation of SOS1. Mol Med
Rep. 8:345–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Piek E, Westermark U, Kastemar M, Heldin
CH, van Zoelen EJ, Nistér M and Ten Dijke P: Expression of
transforming-growth-factor (TGF)-beta receptors and Smad proteins
in glioblastoma cell lines with distinct responses to TGF-beta1.
Int J Cancer. 80:756–763. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kjellman C, Olofsson SP, Hansson O, Von
Schantz T, Lindvall M, Nilsson I, Salford LG, Sjögren HO and
Widegren B: Expression of TGF-beta isoforms, TGF-beta receptors,
and SMAD molecules at different stages of human glioma. Int J
Cancer. 89:251–258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rich JN: The role of transforming growth
factor-beta in primary brain tumors. Front Biosci. 8:e245–e260.
2003. View Article : Google Scholar
|
|
34
|
Golestaneh N and Mishra B: TGF-beta,
neuronal stem cells and glioblastoma. Oncogene. 24:5722–5730. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hover LD, Owens P, Munden AL, Wang J,
Chambless LB, Hopkins CR, Hong CC, Moses HL and Abel TW: Bone
morphogenetic protein signaling promotes tumorigenesis in a murine
model of high-grade glioma. Neuro Oncol. 18:928–938. 2016.
View Article : Google Scholar :
|
|
36
|
Zu L, Xue Y and Wang J, Fu Y, Wang X, Xiao
G, Hao M, Sun X, Wang Y, Fu G and Wang J: The feedback loop between
miR-124 and TGF-β pathway plays a significant role in non-small
cell lung cancer metastasis. Carcinogenesis. 37:333–343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bretones G, Delgado MD and León J: Myc and
cell cycle control. Biochim Biophys Acta. 1849:506–516. 2015.
View Article : Google Scholar
|
|
38
|
Singh G, Singh SK, König A, Reutlinger K,
Nye MD, Adhikary T, Eilers M, Gress TM, Fernandez-Zapico ME and
Ellenrieder V: Sequential activation of NFAT and c-Myc
transcription factors mediates the TGF-beta switch from a
suppressor to a promoter of cancer cell proliferation. J Biol Chem.
285:27241–27250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Z, Zhong L, Zhong S, Xian R and Yuan
B: Adenovirus encoding Smad4 suppresses glioma cell proliferation
and increases apoptosis through cell cycle arrest at G1 phase. Int
Immunopharmacol. 25:169–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kiuchi N, Nakajima K, Ichiba M, Fukada T,
Narimatsu M, Mizuno K, Hibi M and Hirano T: STAT3 is required for
the gp130-mediated full activation of the c-myc gene. J Exp Med.
189:63–73. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin YM, Wang CM, Jeng JC, Leprince D and
Shih HM: HIC1 interacts with and modulates the activity of STAT3.
Cell Cycle. 12:2266–2276. 2013. View Article : Google Scholar : PubMed/NCBI
|
